Pfizer says its vaccine booster provides protection against the Omicron variant


Early data suggests three doses of Pfizer and BioNTech's COVID-19 vaccine provides protection against the new Omicron variant, the companies say.
Pfizer and BioNTech announced Wednesday that a third dose of its COVID-19 vaccine offers a similar amount of protection against the new Omicron variant as two doses of the vaccine does against the original strain of the coronavirus, NBC News reports. The companies also said, however, that preliminary studies indicate two doses "may not be sufficient to protect against infection with the Omicron variant," and a third dose provides "more robust" protection.
"Although two doses of the vaccine may still offer protection against severe disease caused by the Omicron strain, it's clear from these preliminary data that protection is improved with a third dose of our vaccine," Pfizer CEO Albert Bourla said. "Ensuring as many people as possible are fully vaccinated with the first two dose series and a booster remains the best course of action to prevent the spread of COVID-19."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
BioNTech CEO Ugur Sahin added that "our preliminary, first dataset indicate that a third dose could still offer a sufficient level of protection from disease of any severity caused by the Omicron variant."
The news comes less than two weeks after the World Health Organization designated the new Omicron variant a variant of concern. Asked on the Today show whether this new data suggests a two-shot Pfizer regime is "effectively useless" against Omicron, Bourla stressed that there still is "tremendous value" in receiving two doses "compared to if you only have one or if you don't have any."
Bourla added, "It might not be enough on itself, but we are waiting to see. So you may need to go to get the third booster faster, and that's something that the health authorities should consider very carefully and make their recommendations."
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brendan worked as a culture writer at The Week from 2018 to 2023, covering the entertainment industry, including film reviews, television recaps, awards season, the box office, major movie franchises and Hollywood gossip. He has written about film and television for outlets including Bloody Disgusting, Showbiz Cheat Sheet, Heavy and The Celebrity Cafe.
-
Citizenship: Trump order blocked again
Feature After the Supreme Court restricted nationwide injunctions, a federal judge turned to a class action suit to block Trump's order to end birthright citizenship
-
Loyalty tests: The purge at the FBI
Feature Kash Patel is conducting polygraph tests on FBI agents to weed out anyone speaking badly about him
-
The all-seeing tech giant
Feature Palantir's data-mining tools are used by spies and the military. Are they now being turned on Americans?
-
Cytomegalovirus can cause permanent birth defects
The Explainer The virus can show no symptoms in adults
-
Measles cases surge to 33-year high
Speed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive order
speed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts